Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer

The use of oncolytic viruses (OVs) for cancer treatment is emerging as a successful strategy that combines the direct, targeted killing of the cancer with the induction of a long-lasting anti-tumor immune response. Using multiple aggressive murine models of triple-negative breast cancer, we have rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Nikolas Tim, Roy, Dominic Guy, Workenhe, Samuel Tekeste, van den Wollenberg, Diana J. M., Hoeben, Rob C., Mossman, Karen Louise, Bell, John Cameron, Bourgeois-Daigneault, Marie-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372691/
https://www.ncbi.nlm.nih.gov/pubmed/30755678
http://dx.doi.org/10.1038/s41598-018-38385-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372691/
https://www.ncbi.nlm.nih.gov/pubmed/30755678
http://dx.doi.org/10.1038/s41598-018-38385-7

Ejemplares similares